• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconPharmaceutical Industry

Pharmaceutical Industry

Page 35 of 100
General Views of Eli Lilly & Co.
Newsletters
Eli Lilly is teaching an old drug technology new tricks against COVID—and has promising early results
By Sy MukherjeeSeptember 17, 2020
Coronavirus Vaccine Research at Valneva SA Labs
Newsletters
The rollercoaster of COVID-19 vaccines
By Sy MukherjeeSeptember 10, 2020
Pfizer coronavirus vaccine Fortune
Health
Pfizer’s CEO is still hopeful for COVID vaccine progress by October—and says a sense of purpose is fueling him
By Sy MukherjeeSeptember 9, 2020
Image of a syringe injecting a coronavirus in front of an American flag.
Health
Trump wants a COVID-19 vaccine by Election Day. But will one be ready?
By Jeremy KahnSeptember 4, 2020
Steroids COVID death risk
Health
WHO says common steroids can slash death risk for the sickest coronavirus patients
By Sy MukherjeeSeptember 2, 2020
Walgreens hires John Standley, former Rite Aid CEO, to run U.S. unit
Finance
Walgreens hires John Standley, former Rite Aid CEO, to run U.S. unit
By Bloomberg and Angelica LaVitoAugust 31, 2020
Blink Health drug prices exclusive
Health
Why an Amazon and Airbnb vet joined a digital health company that wants to slash drug prices
By Sy MukherjeeAugust 24, 2020
Diversity is long overdue in the drug industry—and it’s going to take more than just hiring Black candidates
Health
Diversity is long overdue in the drug industry—and it’s going to take more than just hiring Black candidates
By Sy MukherjeeAugust 12, 2020
How reborn pharma giant AstraZeneca is taking the lead against COVID-19
Magazine
How reborn pharma giant AstraZeneca is taking the lead against COVID-19
By Jeremy KahnAugust 10, 2020
COVID-19 testing is helping CVS Health win new customers. But can it keep them?
Retail
COVID-19 testing is helping CVS Health win new customers. But can it keep them?
By Phil WahbaAugust 6, 2020
Johnson & Johnson antidepressant spray approved for treating those at risk of suicide
Health
Johnson & Johnson antidepressant spray approved for treating those at risk of suicide
By Cynthia Koons and BloombergAugust 3, 2020
SWITZERLAND-ECONOMY-PHARMA-ROCHE
Newsletters
Roche tried to see if its arthritis drug could fight coronavirus. It didn’t work
By Sy MukherjeeJuly 29, 2020
Who should get get the COVID-19 vaccine?
Commentary
When rationing a coronavirus vaccine, pharma must keep these 3 ethical considerations in mind
By Mike ReaJuly 23, 2020
vaccine injections
Commentary
How to speed up medical breakthroughs in the post-COVID world
By Paul HudsonJuly 15, 2020
Photo of Covid-19 on stock exchange graph.
Finance
Will we have a COVID-19 vaccine this year? Here’s what the prediction markets say
By Jeremy KahnJuly 15, 2020
1...
  • 33
  • 34
  • 35
  • 36
  • 37
...100
Most Popular
Success
Mark Cuban says he has the solution to growing income inequality, and it's to reward every employee—from CEO to janitor—with company stockplaceholder alt text
By Sasha RogelbergJuly 20, 2026
Cybersecurity
OpenAI says its AI models secretly broke out of a secure test environment and hacked into AI company Hugging Face in order to cheat on an evaluationplaceholder alt text
By Jeremy Kahn and Emily ForliniJuly 21, 2026
AI
Mathematicians grapple with a ‘very rapid and very unsettling change’ as AI cracks yet another century-old problemplaceholder alt text
By Eva RoytburgJuly 21, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • TikTok icon
  • YouTube icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.